Cephalon News
Most Popular Cephalon Story
How will Cephalon shift patients to Nuvigil?
Shifting patients from a soon-to-go-off-patent blockbuster to its tweaked successor is old hat in the pharma biz. Ever since drugmakers figured out that adding a time-release coating or other slight... Read more...
Latest Headlines
- February 12, 2010
- February 1, 2010
- January 13, 2010
- December 22, 2009
- December 7, 2009
- August 7, 2009
- May 11, 2009
- March 18, 2009
- March 17, 2009
- November 18, 2008
- September 30, 2008
- September 16, 2008
- May 28, 2008
- May 19, 2008
- May 13, 2008
- May 7, 2008
- May 2, 2008
- March 26, 2008
- February 14, 2008
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
